Biosurfit Company

Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.

Total Funding: €10M
Headquarters: Lisbon, Lisboa, Portugal
Funding Status: Early Stage Venture
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Last Funding Type: Series A
Technology: Genetic Test & Molecular Diagnostics
Investor Type: For Profit
Investors Number: 4
Founded Date: 01.01.2006
Industry: Deep Diagnostics